Tiffany A. Healey

Statistics

Publications

Citations

203

H-Index

Active since

2025

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Tiffany A. Healey is an author at Vertex Pharmaceuticals (United States) specializing in voltage-gated sodium channels, pain pharmacology, and molecular pharmacology.

Publications per year

2025–2025

Publications

Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain

Jeremiah D. Osteen, Swapna Immani, Tim L. Tapley et al. · Pain and Therapy · 2025 · 154 citations · Full text

Medicine, Neurobiology, Pharmacology +17

Suzetrigine, a Non-Opioid NaV1.8 Inhibitor With Broad Applicability for Moderate-to-Severe Acute Pain: A Phase 3 Single-Arm Study for Surgical or Non-Surgical Acute Pain

Jessica McCoun, Peter Winkle, Daneshvari Solanki et al. · Journal of Pain Research · 2025 · 49 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–2 of 2